Sanofi
SNY
$42.78
$0.100.23%
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | 391.55M | -932.44M | 4.47B | 1.97B | |
| Total Depreciation and Amortization | 1.41B | 2.35B | 931.78M | 419.89M | |
| Total Amortization of Deferred Charges | 66.21M | 130.38M | -- | -- | |
| Total Other Non-Cash Items | 2.18B | 372.51M | -3.05B | -187.32M | |
| Change in Net Operating Assets | -673.52M | 2.09B | -695.71M | -- | |
| Cash from Operations | 3.38B | 4.01B | 1.66B | 2.20B | |
| Capital Expenditure | -1.01B | -2.05B | -959.01M | -- | |
| Sale of Property, Plant, and Equipment | 484.02M | 985.99M | 492.56M | -- | |
| Cash Acquisitions | -1.52B | -10.94B | -610.59M | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 1.62B | 9.52B | 11.86B | -816.62M | |
| Cash from Investing | -416.67M | -2.48B | 10.79B | -816.62M | |
| Total Debt Issued | 4.26B | 5.56B | 6.32B | -- | |
| Total Debt Repaid | -1.65B | -4.06B | -1.98B | -- | |
| Issuance of Common Stock | 18.00M | 177.00M | 29.00M | -- | |
| Repurchase of Common Stock | -1.01B | -5.03B | -4.00B | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -5.62B | -5.56B | -5.42B | -- | |
| Other Financing Activities | 1.50B | 5.55B | 517.00M | -592.00M | |
| Cash from Financing | -2.06B | -2.99B | -4.42B | -622.99M | |
| Foreign Exchange rate Adjustments | 11.42M | 8.15M | -24.97M | -21.05M | |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | 364.31M | -163.11M | |
| Net Change in Cash | 913.24M | -1.45B | 8.36B | 578.79M | |